Welcome to the TriologieGroup

Achieving success once may be attributed to luck, but repeating it demonstrates unwavering dedication, strategic effort and a commitment to integrity and reliability—qualities that are indispensable in today's business landscape. This accomplishment would not have been possible without the collective expertise and innovation of our team. The Management would like to extend its sincere appreciation to all employees, whose contributions are vital to our continued success.

Our deepest gratitude goes to our business partners for their trust and collaboration. Your confidence in us has been instrumental in driving our shared achievements. As we look to the future, Triologie is ready to embrace the next way of growth and success together.

Effective July 1st, the executive team of BusinessTriologie expands as the new Chief Operating Officer assumes his position, enhancing our leadership. We warmly welcome Robert Kindervater and wish him great success in his new position.

Effective July 1st, the executive team of InnovationTriologie expands as the new Chief Operating Officer assumes his position, enhancing our leadership. We warmly welcome Dr. Andreas Berk and wish him great success in his new position.

We were represented at this year's DGPharMed congress on April 18^th and 19^th, 2024, in Mainz with two of our own exhibition stands. Detailed explanations and insights into our wide range of services, successful consultations, and information about our training academy ACTA were eagerly sought after. We are very pleased with the numerous interested parties and positive feedback that we were able to record.

On March 21^st, 2024  an expert discussion by InnovationTriologie on the topic “AI in drug development” took place in Berlin. Three engaging keynote speeches shed light on the development and application possibilities of artificial intelligence from various perspectives. This was followed by a discussion round that promoted interdisciplinary exchange. The event provided valuable insights and highlighted the importance of this topic for science, business, and society. 

Supporting the Sonnenhof children's hospice in Berlin (Björn Schulz Stiftung (bjoern-schulz-stiftung.de) is a personal endeavor for all of us. Our donation helps to improving the lives of children with life-limiting illnesses and to support their families in difficult circumstances.

In the 12^th year of the Triologie Group's existence, customer satisfaction is still our top priority. This cooperation is characterized by commitment and pleasure in achieving common project goals under the cost constraints and regulatory density in drug development. New projects in the areas of quality management, project coaching and knowledge management for our customers are both a motivation and an incentive.

Sustainability is an extremely important topic and a central concern of the entire Triologie Group. A large number of measures were already put in place 12 years ago. From the decision in favor of an environmentally focused home office model to the e-mobility strategy, the "Team in Orange" is assuming social responsibility.

We wish all our business partners and their loved ones a joyful and prosperous New Year. Best wishes for 2024. Thank you for trusting us.